Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 26.07%
March 31, 2026 26.38%
December 31, 2025 24.76%
September 30, 2025 23.70%
June 30, 2025 25.86%
March 31, 2025 24.78%
December 31, 2024 24.62%
September 30, 2024 25.55%
June 30, 2024 26.19%
March 31, 2024 26.43%
December 31, 2023 23.83%
September 30, 2023 24.25%
June 30, 2023 21.05%
March 31, 2023 24.49%
December 31, 2022 25.22%
September 30, 2022 24.97%
June 30, 2022 26.46%
March 31, 2022 25.10%
December 31, 2021 26.68%
September 30, 2021 27.06%
June 30, 2021 28.31%
March 31, 2021 27.36%
December 31, 2020 27.98%
September 30, 2020 28.08%
June 30, 2020 28.60%
Date Value
March 31, 2020 29.37%
December 31, 2019 29.20%
September 30, 2019 29.03%
June 30, 2019 29.20%
March 31, 2019 29.48%
December 31, 2018 29.65%
September 30, 2018 29.22%
June 30, 2018 29.61%
March 31, 2018 28.79%
December 31, 2017 30.49%
September 30, 2017 30.02%
June 30, 2017 30.95%
March 31, 2017 32.21%
December 31, 2016 32.76%
September 30, 2016 32.22%
June 30, 2016 32.17%
March 31, 2016 31.92%
December 31, 2015 32.67%
September 30, 2015 32.39%
June 30, 2015 31.70%
March 31, 2015 30.62%
December 31, 2014 30.09%
September 30, 2014 30.34%
June 30, 2014 30.37%
March 31, 2014 29.76%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG 26.95%
Exlites Holdings International, Inc. 0.00%
Xcelerate, Inc. --
Merck KGaA 58.26%
Rafina Innovations, Inc. --